Roger Luo
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 16
- Acute Myeloid Leukemia Research 10
- Chronic Myeloid Leukemia Treatments 5
-
- RNA Interference and Gene Delivery 6
- Protein Degradation and Inhibitors 4
- Co-authors
- Michael J. Thirman (12 shared papers)Federico Simone (4 shared papers)Paul Polak (4 shared papers)Joseph J. Kaberlein (5 shared papers)Catherine Lavau (2 shared papers)Changchun Du (2 shared papers)Francis Y. Lee (5 shared papers)Neil P. Shah (1 shared paper)
- Journals
- Blood (8 papers)Cancer Research (3 papers)Proceedings of the National Academy of Sciences (2 papers)Leukemia (2 papers)Chinese Journal of Cancer (2 papers)
- Partner nations
- United StatesChinaSingapore
In The Last Decade
Roger Luo
30 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 91
- Hematology 510
- Genetics 229
- Rheumatology 185
- Immunology 220
- Molecular Biology 694
Countries citing papers authored by Roger Luo
This map shows the geographic impact of Roger Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Luo more than expected).
Fields of papers citing papers by Roger Luo
This network shows the impact of papers produced by Roger Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Luo. The network helps show where Roger Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Roger Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 207 | |
| 2 | 2008 | 158 | |
| 3 | 2000 | 112 | |
| 4 | 2010 | 111 | |
| 5 | 2011 | 98 | |
| 6 | 2001 | 80 | |
| 7 | 2001 | 74 | |
| 8 | 2003 | 68 | |
| 9 | 2008 | 45 | |
| 10 | BMS-354825 potently inhibits multiple selected oncogenic tyrosine kinases and possesses broad-spectrum antitumor activities in vitro and in vivo | 2005 | 38 |
| 11 | 2003 | 37 | |
| 12 | 2023 | 36 | |
| 13 | 2008 | 34 | |
| 14 | 2009 | 26 | |
| 15 | 2006 | 22 | |
| 16 | 2017 | 20 | |
| 17 | 2013 | 15 | |
| 18 | 2016 | 14 | |
| 19 | 2005 | 14 | |
| 20 | Impact of compliance with proton pump inhibitors on NSAID treatment. | 2009 | 13 |
About Roger Luo
Roger Luo is a scholar working on Hematology, Molecular Biology, Surgery, Genetics and Cancer Research, having authored 30 papers that have together received 1.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (10 papers), RNA Interference and Gene Delivery (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (5 papers), Protein Degradation and Inhibitors (4 papers), Acute Lymphoblastic Leukemia research (3 papers), Cancer Genomics and Diagnostics (3 papers) and Mast cells and histamine (2 papers). The work is most often cited by research in Hematology (510 citations), Genetics (229 citations), Rheumatology (185 citations), Immunology (220 citations) and Molecular Biology (694 citations). Roger Luo has collaborated with scholars based in United States, China and Singapore. Frequent co-authors include Michael J. Thirman, Federico Simone, Paul Polak, Joseph J. Kaberlein, Catherine Lavau, Changchun Du, Francis Y. Lee, Neil P. Shah, Cem Akin and Marjolein L. Donker. Their work appears in journals such as Blood, Cancer Research, Proceedings of the National Academy of Sciences, Leukemia and Chinese Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.